Exforge HCT

Χώρα: Νέα Ζηλανδία

Γλώσσα: Αγγλικά

Πηγή: Medsafe (Medicines Safety Authority)

Δραστική ουσία:

Amlodipine besilate 13.87mg equivalent to amlodipine 10 mg;  ; Hydrochlorothiazide 25mg;  ;  ; Valsartan 320mg;  ;  ;  ;  

Διαθέσιμο από:

Novartis New Zealand Ltd

INN (Διεθνής Όνομα):

Amlodipine besilate 13.87 mg (equivalent to amlodipine 10 mg)

Δοσολογία:

10/320/25mg

Φαρμακοτεχνική μορφή:

Film coated tablet

Σύνθεση:

Active: Amlodipine besilate 13.87mg equivalent to amlodipine 10 mg   Hydrochlorothiazide 25mg     Valsartan 320mg         Excipient: Colloidal silicon dioxide Crospovidone Magnesium stearate Microcrystalline cellulose Opadry red 00F15613 Opadry yellow 00F12951

Μονάδες σε πακέτο:

Blister pack, PA/AL/PVC/AL, 14 tablets

Kατηγορία:

Prescription

Τρόπος διάθεσης:

Prescription

Κατασκευάζεται από:

Lek Pharmaceuticals d.d.

Θεραπευτικές ενδείξεις:

Exforge HCT is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual component formulation with a single component formulation, all components at the same dose level. Treatment should not be initiated with these fixed-dose combinations.

Περίληψη προϊόντος:

Package - Contents - Shelf Life: Blister pack, PA/AL/PVC/AL - 14 tablets - 24 months from date of manufacture stored at or below 30°C protect from moisture - Blister pack, PA/AL/PVC/AL - 28 tablets - 24 months from date of manufacture stored at or below 30°C protect from moisture - Blister pack, PA/AL/PVC/AL - 30 tablets - 24 months from date of manufacture stored at or below 30°C protect from moisture - Blister pack, PA/AL/PVC/AL - 56 tablets - 24 months from date of manufacture stored at or below 30°C protect from moisture

Ημερομηνία της άδειας:

2010-06-29